Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...

Pitted against more established balloon-expandable Sapien 3 valves in TAVR for severe aortic stenosis, the Myval devices ...

Bearish flow noted in Medtronic (MDT) with 25,355 puts trading, or 7x expected. Most active are Jun-25 100 calls and Jan-26 85 puts, with total ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

CHICAGO, IL—A personalized alert system that informs healthcare providers about the detection of severe aortic stenosis on echocardiography and provides recommendations around patient management ...